Moderna Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Moderna Inc.
- Former names
- Moderna Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MRNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001682852
- EIN
- 81-3467528
Board of directors
-
Abbas Hussain · DirectorSince 2024
-
David M. Rubenstein · DirectorSince 2024
-
Elizabeth E. Tallett · DirectorSince 2023
-
Elizabeth G. Nabel · DirectorSince 2023
-
Francois Nader · DirectorSince 2023
-
Michael R. McDonnell · DirectorSince 2026
-
Noubar Afeyan · DirectorSince 2023
-
Paul Sagan · DirectorSince 2023
-
Robert Langer · DirectorSince 2023
-
Sandra Horning · DirectorSince 2023
-
Stephane Bancel · Director · Chief Executive OfficerSince 2023
-
Stephen Berenson · DirectorSince 2023
Chief executives
Stephane Bancel
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 6, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
81.0%
-
98.5%
Board connections
11 of this board's directors also sit on 15 other boards.
- via Noubar Afeyan and Stephane Bancel
- via Michael R. McDonnell
- via Elizabeth E. Tallett
- via Noubar Afeyan
- via Sandra Horning
- via Elizabeth G. Nabel
- via Elizabeth G. Nabel
- via Michael R. McDonnell
- via Paul Sagan
- via Sandra Horning
- via Sandra Horning
- via Robert Langer
- via Stephen Berenson
- via Francois Nader
- via David M. Rubenstein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $64,634,740
- 19 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Hoge Stephen Officer (President) | Option exercise | +76,452 | $12.21 | $933,479 |
| Sep 15, 2026 | Hoge Stephen Officer (President) | Open-market sale | −40,281 | $146.07 | $5,883,846 |
| Sep 14, 2026 | Hoge Stephen Officer (President) | Option exercise | +76,453 | $12.21 | $933,491 |
| Sep 14, 2026 | Hoge Stephen Officer (President) | Open-market sale | −40,294 | $144.13 | $5,807,574 |
| Sep 10, 2026 | Mock James M Officer (Chief Financial Officer) | Option exercise | +19,836 | $30.96 | $614,123 |
| Sep 10, 2026 | Mock James M Officer (Chief Financial Officer) | Open-market sale | −19,836 | $134.49 | $2,667,744 |
| Sep 10, 2026 | Mock James M Officer (Chief Financial Officer) | Open-market sale | −15,000 | $134.49 | $2,017,350 |
| Sep 4, 2026 | Klinger Shannon Thyme Officer (Chief Legal Officer) | Option exercise | +11,797 | — | — |
| Sep 4, 2026 | Mock James M Officer (Chief Financial Officer) | Option exercise | +11,797 | — | — |
| Sep 4, 2026 | Klinger Shannon Thyme Officer (Chief Legal Officer) | Shares withheld for tax | −5,704 | $148.87 | $849,154 |
| Sep 4, 2026 | Mock James M Officer (Chief Financial Officer) | Shares withheld for tax | −5,704 | $148.87 | $849,154 |
| Sep 1, 2026 | Hoge Stephen Officer (President) | Option exercise | +9,283 | — | — |
| Sep 1, 2026 | Klinger Shannon Thyme Officer (Chief Legal Officer) | Option exercise | +3,471 | $30.96 | $107,462 |
| Sep 1, 2026 | Mock James M Officer (Chief Financial Officer) | Option exercise | +2,475 | — | — |
| Sep 1, 2026 | Hoge Stephen Officer (President) | Shares withheld for tax | −4,489 | $140.34 | $629,986 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.